Taro Pharmaceuticals recalls
FDA enforcement reports naming Taro Pharmaceuticals Inc. as the recalling firm.
- Recall reports
- 4
- Class I (serious)
- 0
- Most recent report
- Nov 15, 2023
- Nov 15, 2023Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, MfdDrug · Taro Pharmaceuticals Inc.Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.Class III
- Nov 9, 2016Desoximetasone Cream USP, 0Drug · Taro Pharmaceuticals, Inc.Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).Class II
- Nov 9, 2016Desoximetasone Cream USP, 0Drug · Taro Pharmaceuticals, Inc.Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).Class II
- Sep 2, 2015Topicort (desoximetasone) Topical Spray, 0Drug · Taro Pharmaceuticals, Inc.Failed Impurities/Degradation Specifications: Out of specification results for impurities testing was obtained at the 6 and 9 month time points.Class III